Evidence map›Paper›PMID 41588445›Full record

ArticleArchives of public health = Archives belges de sante publique2026

Inter-physician heterogeneity in colorectal cancer screening participation in France: a study based on the French National Health Data System.

Lydia Guittet, Laurence Pestel, Adrien Grancher, Thibaut Raginel, Panayotis Constantinou, Gonzague Debeugny, Antoine Rachas

Abstract read
In one paragraph

Article in Archives of public health = Archives belges de sante publique, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lydia GuittetUniversité Caen Normandie, CHU Caen Normandie, INSERM ANTICIPE U1086, Caen, F-14000, France. lydia.guittet@unicaen.fr.
Laurence PestelFrench Public Health Insurance Fund (CNAM)/Strategy, Research and Statistics Departement (DSES), Paris, France.
Adrien GrancherDepartment of Hepato-Gastroenterology and Digestive Oncology, CHU Rouen, INSERM ANTICIPE U1086, Rouen, F-76000, France.
Thibaut RaginelDepartment of General Medicine, Université Caen Normandie, INSERM ANTICIPE U1086, Caen, France.
Panayotis ConstantinouFrench Public Health Insurance Fund (CNAM)/Strategy, Research and Statistics Departement (DSES), Paris, France.
Gonzague DebeugnyFrench Public Health Insurance Fund (CNAM)/Strategy, Research and Statistics Departement (DSES), Paris, France.
Antoine RachasFrench Public Health Insurance Fund (CNAM)/Strategy, Research and Statistics Departement (DSES), Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParticipation in the colorectal cancer screening program (CRC-SP) based on biennial faecal occult blood testing is low in France as in many countries. The aim was to evaluate the inter-physician heterogeneity in CRC-SP participation, and its determinants.

methodsThe study used the French National Health Data System. All beneficiaries eligible to CRC-SP (50–74 years old, no history of CRC or inflammatory bowel disease, nor colonoscopy within 5 years) and affiliated to 5,000 general practitioners (GPs) randomly selected from 41,589 eligible liberal GPs (main selection criteria: less than 75 years-old, caseload eligible to CRC-SP > 50, pay-for-performance indicators available) were included. Associations between beneficiaries’ and GPs’ characteristics and 2016–2017 CRC-SP participation, and its inter-physician heterogeneity (intraclass correlation coefficient, ICC) were evaluated using logistic mixed models.

resultsOf the 1.5 million beneficiaries included, 32.2% participated in the CRC-SP. Younger age, male gender, social deprivation and comorbidity score of beneficiaries were associated with lower participation, as well as the absence of GP consultation, or the absence of any healthcare reimbursement in the year before the screening campaign. GPs’ characteristics positively associated with participation were younger age, statutory sector with no extra billing, and high pay-for-performance prevention indicators. The volume of activity was negatively associated with participation. Adjustment on beneficiaries’ characteristics had little effect on the ICC (4.9% vs. 5.2% in the empty model). The ICC decreased after the addition of GPs’ characteristics (4.2%, including age, gender, extra billing, caseload characteristics and volume of activity) and pay-for-performance indicators (2.9%).

conclusionsGPs and healthcare engagement play a key role in CRC screening participation. Improving uptake requires reducing structural barriers, enhancing GP support for prevention, and tailoring strategies to reach vulnerable populations. These findings support multifaceted interventions targeting both patient-level disparities and provider-level capacities to foster better and equitable participation.

trial registrationnot applicable.

Indexed as

Cancer screeningColorectal cancerHealthcare systemMedical practicesPrimary care

Identifiers

PMID41588445
PMCPMC12914895

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.